small molecule therapeutics for bone lesions in cancer (Molplex Pharmaceuticals)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Namesmall molecule therapeutics for bone lesions in cancer (Molplex Pharmaceuticals)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBone modulators
TargetsUpdating
Therapy Area/IndicationsFractures, Bone
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMolplex Pharmaceuticals Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMolplex Pharmaceuticals Ltd
Active IndicationsN/A
Inactive IndicationsFractures, Bone

Other Information

ATC CodeN/A
Related LinksN/A